SCHEMBL6174392

SCHEMBL6174392

CC(C)(C)CC(=O)Nc1ccc2c(c1)cc(OC(=O)O)n2-c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 14/20 0.67
HPGD P15428 3/20 0.47
MAPT P10636 2/20 0.47
GAA P10253 1/20 0.47
RAB9A P51151 1/20 0.47
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
KCNQ3 O43525 1/20 0.43
KCNQ2 O43526 1/20 0.43
KCNQ4 P56696 1/20 0.43
KCNQ5 Q9NR82 1/20 0.43
ALDH1A1 P00352 3/20 0.41
LMNA P02545 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
USP2 O75604 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HCRTR1 O43613 1/20 0.41
TP53 P04637 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173723 0.89 ECE1 (0.62) ECE1HPGDMAPTGAARAB9A
SCHEMBL6018546 0.83 ECE1 (0.82) ECE1HPGDMAPTGAARAB9A
SCHEMBL6069195 0.80 ECE1 (1.00) ECE1HPGDMAPTGAARAB9A
SCHEMBL6019583 0.80 ECE1 (0.73) ECE1HPGDMAPTGAARAB9A
SCHEMBL6175629 0.79 ECE1 (0.71) ECE1
SCHEMBL6018853 0.79 ECE1 (0.92) ECE1HPGDMAPTGAARAB9A
SCHEMBL6174890 0.78 ECE1 (0.72) ECE1
SCHEMBL8363860 0.77 ECE1 (0.88) ECE1
SCHEMBL6177176 0.74 ECE1 (0.82) ECE1
SCHEMBL9241483 0.73 KDM4E (0.51) HPGDMAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432415-B1 SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER HEALTHCARE AG (DE) 2005-12-28 EP disclosed
EP-1432415-A1 SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES Bayer HealthCare AG (DE) 2004-06-30 EP disclosed
WO-2003028719-A1 SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER HEALTHCARE AG (DE) 2003-04-10 WO disclosed